MedPath

The Momentum Program: Online Cognitive Behavioural Therapy (CBT) for Adolescent Anxiety and Depression Comorbidity

Not Applicable
Recruiting
Conditions
Anxiety
Depression
Mental Health - Anxiety
Mental Health - Depression
Registration Number
ACTRN12622001381774
Lead Sponsor
Griffith University
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
270
Inclusion Criteria

Following registration and the initial assessment process that is part of the open access Momentum Platform, adolescents aged 13-17 years who are found to demonstrate comorbid anxiety and depression symptoms will be invited to participate in the study. Participants must be willing to participate in either of the two conditions (COM or PRI).

Exclusion Criteria

Potential participants will be excluded if the adolescent (i) has an intellectual or a developmental disorder (autism, developmental delay); (ii) is receiving other psychological/psychiatric treatment for their primary problem (anxiety or depression); (iii) is not stabilised on a medication prior to enrolment into this study or alters their medication dosage during the trial (if the participant is using medication for anxiety or depression); (iv) displays a high suicidal risk (i.e., a score >21 on the Suicidal Ideation Attributes Scale by Van Spijker et al. (2014)).

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Youth depressive symptoms<br><br>Depressive symptoms will be assessed with the Centre for Epidemiological Studies Depression Scale for adolescents (CES-D; Radloff, 1991). [ Pre-intervention, 3-month post-baseline (primary endpoint), 9-month post-baseline follow up];Youth anxiety symptoms<br><br>Anxiety symptoms will be assessed with the Spence Children’s Anxiety Scale (SCAS; Spence, 1998).[ Pre-intervention, 3-month post-baseline (primary endpoint) 9-month post-baseline follow up]
Secondary Outcome Measures
NameTimeMethod
Quality of life<br><br>Quality of life will be assessed with the Child Health Utility 9 Index (CHU9D; Ratcliffe et al., 2012).[ Pre-intervention<br>Post-completion of program<br>6-month post-baseline follow up<br>12-month post-baseline follow up];Treatment satisfaction and acceptability<br><br>Treatment satisfaction and acceptability will be assessed at post-intervention with a 6-item questionnaire adapted from March et al. (2009), in which young people are asked to rate their program satisfaction on a 5-point scale. [ Post-completion of program]
© Copyright 2025. All Rights Reserved by MedPath